• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Remeron and Remeron SolTab (mirtazapine) tablets and orally disintegrating tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2012

Summary View

 

CONTRAINDICATIONS

  • Starting Remeron in a patient who is being treated with MAOIs such as linezolid or intravenous methylene blue is also contraindicated because of an increased risk of serotonin syndrome
 

WARNINGS

  • There may be circumstances when it is necessary to initiate treatment with an MAOI such as linezolid or intravenous methylene blue in a patient taking Remeron. Remeron should be discontinued before initiating treatment with the MAOI.
 

MEDICATION GUIDE

Who should not take Remeron?
Do not take Remeron
  • Ask your healthcare provider or pharmacist if you are not sure if you take an MAOI, including the antibiotic linezolid.